CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-02 | COZADD BRUCE C Chairman & CEO | Sale 10b5-1 | −500 | $120.00 | $60K | 438,807 |
| 2025-05-01 | COZADD BRUCE C Chairman & CEO | Sale 10b5-1 | −1,000 | $116.35 | $116K | 439,307 |
| 2025-04-01 | COZADD BRUCE C Chairman & CEO | Sale 10b5-1 | −1,500 | $123.75 | $186K | 440,307 |
| 2025-03-10 | Iannone Robert EVP, Global Head of R&D & CMO | Sale | −2,403 | $138.41 | $333K | 79,621 |
| 2025-03-10 | Carr Patricia SVP, Chief Accounting Officer | Sale | −1,140 | $137.81 | $157K | 7,012 |
| 2025-03-07 | Henderson Mary Elizabeth SVP, Technical Operations | Returned to the company | −698 | $138.23 | $96K | 23,077 |
| 2025-03-07 | Carr Patricia SVP, Chief Accounting Officer | Returned to the company | −1,333 | $138.23 | $184K | 8,152 |
| 2025-03-07 | Iannone Robert EVP, Global Head of R&D & CMO | Sale 10b5-1 | −5,532 | $138.21 | $765K | 83,572 |
| 2025-03-07 | Iannone Robert EVP, Global Head of R&D & CMO | Sale 10b5-1 | −1,548 | $140.00 | $217K | 82,024 |
| 2025-03-05 | Pearce Samantha EVP, Chief Commercial Officer | Returned to the company | −1,905 | $138.95 | $265K | 41,226 |
| 2025-03-05 | Patil Neena M EVP & Chief Legal Officer | Returned to the company | −4,088 | $138.95 | $568K | 47,526 |
| 2025-03-05 | Johnson Philip L EVP & Chief Financial Officer | Returned to the company | −1,149 | $138.95 | $160K | 50,060 |
| 2025-03-05 | Iannone Robert EVP, Global Head of R&D & CMO | Returned to the company 10b5-1 | −5,239 | $138.95 | $728K | 89,104 |
| 2025-03-05 | GALA RENEE D President & COO | Returned to the company | −5,704 | $138.95 | $793K | 88,895 |
| 2025-03-05 | COZADD BRUCE C Chairman & CEO | Returned to the company | −22,251 | $138.95 | $3.1M | 441,807 |
| 2025-03-03 | COZADD BRUCE C Chairman & CEO | Sale 10b5-1 | −6,500 | $144.25 | $938K | 464,058 |
| 2025-02-28 | Carr Patricia SVP, Chief Accounting Officer | Sale | −773 | $143.30 | $111K | 9,485 |
| 2025-02-27 | Iannone Robert EVP, G R&D and CMO | Grant or award | +17,718 | 85,484 | ||
| 2025-02-27 | Iannone Robert EVP, G R&D and CMO | Grant or award | +8,859 | 94,343 | ||
| 2025-02-27 | Henderson Mary Elizabeth SVP, Technical Operations | Grant or award | +5,392 | 19,923 |
Page 12 of 31 · 614 trades